OrbiMed’s Acutus Medical Inc AFIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,648,386
| Closed | -$498K | – | 126 |
|
|
2024
Q1 | $498K | Hold |
2,648,386
| – | – | 0.01% | 111 |
|
|
2023
Q4 | $535K | Hold |
2,648,386
| – | – | 0.01% | 109 |
|
|
2023
Q3 | $1.84M | Hold |
2,648,386
| – | – | 0.04% | 113 |
|
|
2023
Q2 | $2.35M | Hold |
2,648,386
| – | – | 0.04% | 114 |
|
|
2023
Q1 | $2M | Hold |
2,648,386
| – | – | 0.04% | 113 |
|
|
2022
Q4 | $3.05M | Hold |
2,648,386
| – | – | 0.06% | 99 |
|
|
2022
Q3 | $2.33M | Hold |
2,648,386
| – | – | 0.04% | 120 |
|
|
2022
Q2 | $2.97M | Hold |
2,648,386
| – | – | 0.05% | 123 |
|
|
2022
Q1 | $3.68M | Hold |
2,648,386
| – | – | 0.06% | 126 |
|
|
2021
Q4 | $9.03M | Hold |
2,648,386
| – | – | 0.12% | 119 |
|
|
2021
Q3 | $23.4M | Sell |
2,648,386
-2,829,572
| -52% | -$37.2M | 0.26% | 89 |
|
|
2021
Q2 | $93M | Hold |
5,477,958
| – | – | 0.94% | 33 |
|
|
2021
Q1 | $73.2M | Hold |
5,477,958
| – | – | 0.68% | 45 |
|
|
2020
Q4 | $158M | Hold |
5,477,958
| – | – | 1.38% | 18 |
|
|
2020
Q3 | $163M | Buy |
+5,477,958
| New | +$166M | 2.05% | 14 |
|
Other funds holding AFIB
OrbiMed's AFIB Position: Q2 2024 in Review
OrbiMed sold out of Acutus Medical Inc (AFIB) in Q2 2024, closing a stake of 2,648,386 shares — an estimated $498K sold.
OrbiMed first reported a position in AFIB in Q3 2020 and held it in 15 quarters. The position peaked at $163M in Q3 2020. 1 fund tracked by Wall St. Rank holds AFIB as of Q2 2024.
- OrbiMed reported no remaining Acutus Medical Inc position as of Q2 2024 after selling out during the quarter.
- OrbiMed sold 2,648,386 Acutus Medical Inc shares in Q2 2024, an estimated $498K.
- OrbiMed first reported a position in Acutus Medical Inc in Q3 2020 and held it in 15 quarters.
- OrbiMed's Acutus Medical Inc position peaked at $163M in Q3 2020.
- 1 fund tracked by Wall St. Rank held Acutus Medical Inc as of Q2 2024.
Based on OrbiMed's 13F filing for Q2 2024, filed 14 Aug 2024.